Prostate-specificmembrane antigen (PSMA) and gastrin-releasingpeptide receptor (GRPR) have been used for diagnostic molecular imaging/therapyof prostate cancer (PCa). The gene discussed is FOLH1; the disease is posterior cortical atrophy.